Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3. - Younossi, Z. M.; Stepanova, M.; Jacobson, I. M.; Asselah, T.; Gane, E. J.; Lawitz, E.; Foster, G. R.; Roberts, S. K.; Thompson, A. J.; Willems, B. E.; Welzel, T. M.; Pearlman, B.; et al. (Alimentary Pharmacology & Therapeutics, 2018)